双鹭药业(002038.SZ)参股公司轩竹生物预计于10月15日在联交所挂牌上市

Core Viewpoint - Shuanglu Pharmaceutical (002038.SZ) announced that its associate company, Xuan Zhu Bio (02575), is expected to officially list on the Hong Kong Stock Exchange on October 15, 2025, with a global offering of 67.335 million shares priced at HKD 11.60 per share [1] Company Summary - Shuanglu Pharmaceutical holds a total of 1.7808 million shares in Xuan Zhu Bio, which is expected to represent 0.34% of the total shares post-issuance [1] - The lock-up period for the shares held by Shuanglu Pharmaceutical will last for 12 months following the listing of Xuan Zhu Bio [1]